Page last updated: 2024-11-03

procarbazine and Preleukemia

procarbazine has been researched along with Preleukemia in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Preleukemia: Conditions in which the abnormalities in the peripheral blood or bone marrow represent the early manifestations of acute leukemia, but in which the changes are not of sufficient magnitude or specificity to permit a diagnosis of acute leukemia by the usual clinical criteria.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pflieger, H1
Wiesneth, M1
Arnold, R1
Niethammer, D1
Kleihauer, E1

Other Studies

1 other study available for procarbazine and Preleukemia

ArticleYear
Granulocyte transfusions in children.
    European journal of pediatrics, 1981, Volume: 135, Issue:3

    Topics: Acute Disease; Agranulocytosis; Anemia, Aplastic; Antilymphocyte Serum; Blood Transfusion; Bone Marr

1981